2010 CEND Symposium - Mechanisms of Drug Therapy and Resistance in HIV and TB - Part 2 Clifton Barry, National Institutes of Health - "Dirty by design: Rational Approach to Development of Antitubercular Nitroimidazoles" http://globalhealth.berkeley.edu/cend/ Funding for this conference was made possible in part by Grant 1R24TW008822 from the NIH Fogarty International Center. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the NIH; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.